Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cerilliant
Medtronic
Harvard Business School
Queensland Health
Argus Health
UBS
Teva
Fish and Richardson
Citi

Generated: February 19, 2018

DrugPatentWatch Database Preview

Daunorubicin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for daunorubicin hydrochloride and what is the scope of daunorubicin hydrochloride freedom to operate?

Daunorubicin hydrochloride
is the generic ingredient in two branded drugs marketed by Sanofi Aventis Us, West-ward Pharms Int, Wyeth Ayerst, Fresenius Kabi Usa, Teva Parenteral, and Teva Pharms Usa, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for daunorubicin hydrochloride. One supplier is listed for this compound.
Pharmacology for daunorubicin hydrochloride

US Patents and Regulatory Information for daunorubicin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065035-001 Jan 24, 2000 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 050731-001 Jan 30, 1998 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Ayerst CERUBIDINE daunorubicin hydrochloride INJECTABLE;INJECTION 050484-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us CERUBIDINE daunorubicin hydrochloride INJECTABLE;INJECTION 061876-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Parenteral DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 064212-002 May 3, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065034-001 Nov 20, 2001 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 065000-001 May 25, 1999 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Parenteral DAUNORUBICIN HYDROCHLORIDE daunorubicin hydrochloride INJECTABLE;INJECTION 064212-001 Jun 23, 1998 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int CERUBIDINE daunorubicin hydrochloride INJECTABLE;INJECTION 064103-001 Feb 3, 1995 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Johnson and Johnson
Harvard Business School
Federal Trade Commission
Boehringer Ingelheim
Fish and Richardson
AstraZeneca
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot